Completed

Endotoxin Effects on Cardiopulmonary Function in Healthy Volunteers

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This phase 1 study aims to investigate how endotoxins affect the heart and lung function in healthy individuals.

What is being tested

Reference Endotoxin

+ Inhaled Nitric Oxide

Drug
Who is being recruted

Infections+7

+ Inflammation

+ Pathologic Processes

From 18 to 45 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 1
Interventional
Study Start: April 1992
See protocol details

Summary

Principal SponsorNational Institutes of Health Clinical Center (CC)
Last updated: July 5, 2018
Sourced from a government-validated database.Claim as a partner

Study start date: April 6, 1992

Actual date on which the first participant was enrolled.

Endotoxin is a unique molecule because it represents an important probe for investigating the humoral and cellular basis of septic shock. Endotoxin administration to humans provides an opportunity to evaluate the earliest responses that are activated after exposure to an important bacterial component. Many alterations in organ function and circulating mediators can be evaluated in this model. These changes are qualitatively similar to changes that occur during sepsis and septic shock. The applications of new technologies to this model are useful adjuncts to define mechanisms of acute inflammatory responses. Defining these pathways and their interactions may allow a better understanding of the factors that can be controlled or altered during critical illness. In the current study, we are planning to extend previous observations on heart and lung function after endotoxin administration in four separate studies. Bronchoalveolar lavage and bronchial brushings in normal subjects. Bronchoalveolar lavage and bronchial brushings will be performed in normal subjects to obtain alveolar and epithelial pulmonary cells for use in vitro assays of respiratory cell function. Inflammatory effects of systemic endotoxin administration. In order to evaluate late inflammatory responses to IV endotoxin, blood will be obtained acutely and at 1, 2, 3, 7, and 14 days post endotoxin challenge. Pulmonary effects of instilled endotoxin. Using bronchoscopy, the effects of direct instillation of endotoxin into a lobe of the lung is being used to assess local pulmonary inflammatory responses that result in neutrophil influx into the lung. Effects of inhaled nitric oxide on pulmonary inflammatory responses following endotoxin administration. In order to systematically study the effects of inhaled nitric oxide on local lung inflammation, healthy subjects will undergo local endotoxin instillation, breath NO through a mask for 6h, and then a repeat bronchoscopy will be done at 6h to assess the ability of NO to suppress local inflammation in the lung.

NCT00001303
Principal SponsorNational Institutes of Health Clinical Center (CC)
Last updated: July 5, 2018
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

198 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 45 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

InfectionsInflammationPathologic ProcessesRespiratory Tract DiseasesShockPathological Conditions, Signs and SymptomsSystemic Inflammatory Response SyndromeLung DiseasesShock, SepticSepsis

Criteria

INCLUSION CRITERIA: 18 to 45 years of age, either male or female Employees or non-employees are eligible Normal screening examination: history and physical examination, nonsmoker, no concurrent medications including aspirin or nonsteroidal anti-inflammatory drugs, no active medical problems; complete blood count with differential and platelet counts; serum chemistries including creatinine, blood urea nitrogen, glucose, liver enzymes and function tests, electrolytes, prothrombin time, partial thromboplastin time; urinalysis; female subjects must have negative urine pregnancy test within one week of participation; electrocardiogram; chest radiograph. If age is 40 to 45 years, normal submaximal stress test to screen for asymptomatic coronary artery disease. EXCLUSION CRITERIA: Pregnancy. Lactation. History of recent clinically significant asthma. Subjects who have an allergy to both sulfa- and penicillin-based drugs will not be eligible for the endotoxin instillation portion of the study.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United StatesOpen National Institutes of Health Clinical Center, 9000 Rockville Pike in Google Maps
CompletedOne Study Center